Yolanda Caringal

Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach

Roger A. Smith, J A Barbosa, Cheri L. Blum et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 85 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

Anikó M. Redman, Jeffrey S. Johnson, Robert Dally et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors

Uday R. Khire, Donald Bankston, J A Barbosa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

A new route to benzo[a]naphthacene-8,13-diones: synthesis and revision of the structure proposed for G2N

Frank M. Hauser, Yolanda Caringal · The Journal of Organic Chemistry · 1990 · 32 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

Discovery of ((<i>S</i>)-5-(Methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I_Kur Inhibitor

Heather J. Finlay, John Lloyd, Wayne Vaccaro et al. · Journal of Medicinal Chemistry · 2012 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16